Evaluation of safety margins of Chenopodium album seed decoction: 14-day subacute toxicity and microbicidal activity studies by Kumar, Shrabanti et al.
RESEARCH Open Access
Evaluation of safety margins of Chenopodium
album seed decoction: 14-day subacute toxicity
and microbicidal activity studies
Shrabanti Kumar, Shampa Biswas, Sukdeb Banerjee and Nirup B Mondal
*
Abstract
Background: Sperm immobilizing activity and plausible mechanism of action of Chenopodium album seed
decoction (CAD) have been elucidated in our earlier studies. The present study has been carried out to explore the
safety standards of CAD along with microbicidal properties as prerequisite for its use as a topically applicable
vaginal contraceptive.
Methods: The safety standards of CAD were assessed by a) Hemolytic index determination using rabbit
erythrocytes, to set the doses of the other experiments, b) Dermal irritancy test using refined version of Draize
scoring system on rabbits, c) Possible effect on local tissues and reproductive performance in female rats after
fourteen daily single dose application, d) PCNA staining- to evaluate the effect of CAD on vaginal tissue
proliferation, e) TUNEL assay- to examine its ability to induce in situ apoptosis in the vaginal tissue sections of the
treated animals, and f) Microbicidal activity- to explore the effect of CAD on the growth of Lactobacillus acidophilus
and Candida albicans.
Results: In vitro irritation studies on rabbit erythrocytes revealed the hemolytic index of CAD to be 8.2 mg/ml. The
dermal irritation test showed it to be a non-irritant even at higher doses. Intra vaginal application of CAD in rat
vagina for 14 consecutive days caused slight reversible inflammation on vaginal epithelial cells at doses as high as
82 mg/ml. However, at this dose level it neither had any adverse effect on vaginal tissue proliferation nor did it
cause in situ apoptosis as evident from PCNA staining and TUNEL assay. Fertility and fecundity were restored 4-15
days after withdrawal of CAD application. At dose level 10 times that of its spermicidal MEC (minimum effective
concentration), CAD did not block the growth of Lactobacillus, although the size of individual colony was
marginally reduced. However, growth of the pathogenic fungus Candida albicans was completely inhibited with 20
mg/ml of CAD.
Conclusion: The overall result evolved from the study strengthens the candidature of CAD as a safe microbicidal
spermicide. It is almost non-irritant to rabbit skin and rat vaginal tissues at doses 10 fold higher than its hemolytic
index. The effect of CAD on Lactobacillus culture was not highly encouraging but it prevented the growth of the
fungal pathogen Candida albicans at 20 mg/ml of CAD.
Background
The vaginal contraceptive products available so far are
mostly based on Nonoxynol-9 (N-9), a mixture of oligo-
mers [1]. As the healthcare industry moves towards
using either pure compounds or mixtures whose indivi-
dual components meet safety standards, the use of N-9
may or may not meet future safety regulations. Several
European nations have already banned or restricted the
use of N-9 and related detergent type spermicides,
because repeated usage of these types of detergent type
spermicides has been shown to cause vaginal/cervical
irritation and even ulceration [2]. In addition, distur-
bance of the normal vaginal micro flora facilitates
microbial infection and renders the subject susceptible
to sexually transmitted diseases (STDs) [3]. Thus,
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agent is the need of the day.
In our previous communications [4,5] we have dis-
cussed the spermicidal potential and plausible mechan-
ism of action of Chenopodium album seed decoction
(CAD). But unambiguous establishment of sperm killing
activity is not enough to recommend it for clinical use
unless its safety margin is ascertained in experimental
animal models. It is well known that vaginal spermicides
are products for topical application and are meant for
use to prevent unintended pregnancies, besides offering
protection against sexually transmitted diseases (STDs),
including infection by human immunodeficiency virus
(HIV). In general, topically applicable spermicidal mole-
cules are exposed to the specific organs during their
administration to the vaginal walls. Thus tolerance tests
for specific organs prior to human exposure are very
important. Moreover, recent studies on currently avail-
able vaginal spermicides have revealed that they do not
actually provide protection against STDs; rather long
term use of such detergent type spermicides is asso-
ciated with vaginal ulceration, which facilitates the entry
of foreign pathogens [6]. Keeping in view the toxic
effects exerted by the existing spermicidal agents, we
carried out a series of safety measurement studies with
CAD in experimental animals.
Mammalian vaginal bacterial flora comprising of Acid-
ophilus play a major role in maintaining vaginal health
by prohibiting growth of other pathogenic microbes and
STDs [7]. No spermicidal preparation is acceptable if it
has any deleterious effect on the normal vaginal flora.
Taking this fact into consideration we studied the effect
of CAD on the growth of Lactobacillus acidophilus a
normal habitat of women vagina. On the other hand,
Candida albicans is the most commonly encountered
fungal pathogen of the human vagina [8]. We therefore
took this strain as representative pathogenic strain and
explored the effect of CAD on its growth. Moreover,
considering the detrimental effect of CAD on sperm
DNA [5], it was necessary to examine whether continu-
ous application of CAD may disturb the physiological
processes that normally occur during the estrous cycle
such as proliferation and apoptosis.
Methods
Animals
Toxicology studies were conducted in both rodent (viz.
rat) and non-rodent (viz. rabbit) species. Animals were
maintained under light and temperature control (com-
plying with standard husbandry conditions) with food
and water adlibitum and were acquired from our insti-
tute’s animal facility. All experiments were performed in
accordance with the guidelines formulated by the animal
ethics committee of Indian Institute of Chemical
Biology.
Experiment-1
Determination of hemolytic index for ascertaining the in
vitro cytotoxic dose
Haemolytic index, i.e. the concentration required for
50% hemolysis of [9] RBCs, was ascertained for CAD to
determine the subsequent doses to be used for topical
application in sub acute toxicity studies. Freshly isolated
rabbit blood in isotonic PBS (35 mM phosphate buffer,
150 mM NaCl, pH 7.0) was initially centrifuged at 2000
g for 10 minutes. RBCs were washed (3 x) and resus-
pended (130 × 10
6cells/ml) in PBS, pH 7.4. Test samples
were prepared by combining 0.5 ml of the RBC suspen-
s i o nw i t h3m lo fP B Sc o n t a i n i n g2m g / m l ,4m g / m l ,8
mg/ml and 10 mg/mlof CAD for 30 min. Negative con-
trols were prepared by replacing the CAD solution by
PBS. Positive controls were prepared by incubating the
cells with 1% Triton-X 100. In addition, positive control
samples underwent sonication and mild shaking to
ensure complete hemolysis of the sample. All samples
were run in triplicate. The experimental samples were
centrifuged (1000 g) for 3 min and placed in ice bath to
quench the hemolytic reaction. Following the quenching
of the hemolytic process, the absorbance of the superna-
tant of each sample was determined at 576 nm. The
percentage of hemolysis was calculated on the basis of
the following equation.
%H=1 0 0 %(Abs − Abscontrol)/(Abs100 − Abscontrol)
where Abs is the absorbance of the sample, Abscontrol
is the absorbance of the control sample (negative con-
trol), and Abs100 is the absorbance of the sample in
which 100% hemolysis occurred (positive control).
Experiment-2
Safety studies in experimental animal model
Low volume eye test (LVET) Low volume eye test
(LVET) [10] is the refined version of Draize eye irritancy
test [11] that uses 1/10
th volume of the test substance
placed directly on the cornea. The level and duration of
eye irritation in the LVET are less than those in the
Draize procedure, which means that it is a less stressful
test. Moreover LVETs are more predictive of human
response.
In this test one eye served as the target and the other
as control. On the day of dosing, the test material (0.1
ml of 8.2 mg/ml or 82 mg/ml of CAD in physiological
saline) was applied into the conjunctival sac of one eye
of three rabbits. The lower eyelid was held open
momentarily during dosing. The eyelids were then
gently held together for a moment and then released to
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rabbit was treated similarly with normal saline and
served as a control. The cornea, iris, and conjunctiva of
the treated and control eyes were examined at 1, 24, 48,
and 72 hr after treatment. The degree of eye irritation
was evaluated following the criteria of Draize et al [11].
Dermal irritation test
Since a clinical formulation is yet to be prepared, a gale-
nic formulation of CAD prepared with K-Y Jelly (John-
son and Johnson India Ltd., Mumbai, India) at
hemolytic dose (8.2 mg/ml), at a dose (82 mg/ml) 10
fold higher than the hemolytic index, and saline (pla-
cebo) were applied topically (0.5 ml per site, applied
uniformly on a 2.5 cm × 2.5 cm area) to one intact and
one abraded test sites per rabbit. The test sites were
occluded by covering each site with a dressing gauze
pad (3 × 3 cm) and over wrapping the site with a perfo-
rated nonirritating plastic tape (100 μm) for 24 hr fol-
lowing application of the gel. Dermal irritation was
measured following the index of Draize scoring system
at 24, 48 and 72 hour after gel application [11].
No irritation - 0.00
Irritation barely perceptible - 0.04 - 0.99
Slight irritation - 1.00 - 1.99
Mild irritation - 2.00 - 2.99
Moderate irritation - 3.00 - 5.99
Severe irritation - 6.00 - 8.00
Experiment- 3
Test for possible effect and reproductive performance in
female rats after fourteen daily single dose applications
Twelve female Sprague-Dawley rats having regular four-
day estrous cycle were used in this evaluation. The ani-
mals were divided into four groups each consisting of
three rats. K-Y jelly based CAD, at doses 8.2 mg/ml and
82 mg/ml, was administered intra vaginally in each ani-
mal (100 μl) of two groups for 14 consecutive days. The
formulations were placed deep into the vagina through
a syringe. The first group (Group I) was left untreated,
the second group (Group II) was treated with only K-Y-
jelly (the placebo), the third group (Group III) received
a dose of 8.2 mg/ml (hemolytic index), and the fourth
group (Group IV) received a dose of 82 mg/ml (10×
hemolytic index). Rats were individually observed daily
for overt clinical signs (vaginal swelling, redness, and
discharge including bleeding). The change in the regu-
larity of estrous cycle was observed by microscopical
examination of vaginal lavage. Each of the female rats in
their proestrous phase was placed after completion of
the treatment in the cage of a proven male and next day
its vaginal smear was examined. Presence of sperm in
the lavage was considered successful mating and day-1
of pregnancy. The mated females were allowed to com-
plete their term and the litter size and body weights of
the pups were recorded for comparison with the control
group. The pups were maintained until weaning and
their general growth rates were compared with those of
pups from the control group.
Experiment- 4
Effect of 14-day (sub acute) vaginal administration of high
doses of CAD on local tissues, vaginal tissue proliferation,
and in situ apoptosis
Regularly cycling 12 adult Sprague Dawley rats were
divided into four groups (control and treated). Animals
of Group-I served as untreated control and those of
Group-II were treated with placebo gel (K-Y jelly only).
Animals of Group-III and Group-IV were treated vagin-
ally with 8.2 mg/ml and 82 mg/ml of CAD solution in
K-Y jelly respectively. All animals were weighed on the
first day of dosing and every seventh day thereafter, and
were sacrificed at the end of the treatment schedule.
The vaginal tissues were slit open ventrally between the
urethral orifice and fornix. Representative samples of
the proximal, middle and distal portions were collected
and fixed in 10% neutral buffered formalin fixative.
Fixed tissues were embedded in paraffin, sectioned at
thickness of 5 μm, stained with hematoxylin and eosin,
and examined under × 200 magnification using a Leica
light microscope (Milton Keynes, Buckinghamshire, UK)
interfaced with an image analysis system. The images
were captured using the image pro plus program in con-
junction with a 3CCD camera and images were trans-
ferred to Adobe Photoshop 7.0 software for observation
and analysis. The vaginal tissue sections were observed
for epithelial ulceration, edema, leukocyte infiltration,
and vascular congestion.
Cell proliferation (PCNA staining)
The expression level of Proliferating Cell Nuclear Anti-
gen (PCNA) has broad correlation with mitotic activities
and therefore can be used as a marker for cell prolifera-
tion. Here PCNA staining was performed to evaluate the
cell-proliferating activity of CAD treated vaginal tissues.
Immunohistochemistry of tissue sections was performed
using Zymed PCNA kit (South San Francisco, CA).
Deparaffinised tissue sections were treated to remove the
endogenous peroxidase activity, and then incubated with
a biotinylated anti-PCNA monoclonal antibody. Sections
were washed in phosphate buffered saline (PBS), incu-
bated with streptavidin-peroxidase for 30 minute at room
temperature, and washed with PBS. Positive control con-
sisted sections of mouse intestine known to express
PCNA and negative control were prepared with the sec-
tions stained without the primary antibody. The bound
horseradish peroxidase complexes were developed using
diaminobenzidine tetrahydrochloride according to the
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stained with Harris’ hematoxylin, dehydrated, mounted
with glass cover slips, and were then observed under a
Leica light microscope (Milton Keynes, Buckinghamshire,
UK). The nature of staining and the distribution of
PCNA reactivity were determined by scoring a minimum
of 100 cells in the vaginal tissue sections in several ran-
dom fields and percentage of PCNA positive cells were
calculated in each field.
In situ apoptosis (TUNEL assay)
The ability of CAD to induce in situ apoptosis in rat
vaginal tissue was evaluated by the terminal deoxynu-
cleotidyl transferase (TdT)-mediated digoxigenin-uridine
triphosphate (dUTP) nick-end labeling (TUNEL) assay,
which labels the exposed 3
’ hydroxyl ends of fragmen-
tated nuclear DNA [12]. The assay was performed by
u s i n gt h eD N Af r a g m e n t a t i o nk i to b t a i n e df r o mC l o n -
tech Laboratories Inc. (Mountain view, CA, USA). This
kit uses a direct labeling procedure for detecting DNA
fragmentation at the single-cell level. Control and CAD
treated tissue sections were deparaffinised and rehy-
drated in graded alcohol. The tissue sections were then
treated with proteinase k (20 μg/ml) for 15 min at room
temperature to digest nuclear matrix protein and expose
the chromatin. Sections were then incubated for 1 hr
with TdT and FITC-dUTP in a humidified chamber at
37°C. After terminating the reaction, sections were
washed in PBS and nuclear staining was performed by
counterstaining the sections with propidium iodide (PI,
1 μg/ml). Positive control slides were prepared by treat-
ing the control sections with DNase (2 μg/ml) in reac-
tion buffer [13] for 10 minute prior to TUNEL staining.
Negative controls were prepared by omitting TdT from
the reaction mixture. These were then observed under
an Olympus Bx51 fluorescence microscope (Olympus
Corporation, Lake Success, NY) and the TUNEL positive
cells were counted in several random fields per tissue
section (x200) and the percentage of TUNEL positive
cells were determined.
Experiment- 5
Tests for microbicidal activity of CAD
Effect of CAD on Lactobacillus acidophilus The media
for culture of bacteria were purchased from M/s Hi-
Media Laboratories Pvt. Limited, Mumbai, India. Spores
of Lactobacillus acidophilus were obtained from phar-
maceutical capsules marketed by Infar (India) Limited.
To obtain direct counts of lactobacilli, sterile, molten
(45-50°C) Lactobacilli MRS agar was poured into sterile
Petri dishes with CAD or without CAD. Test plates in
triplicate containing 2 mg/ml(at MEC), 10 mg/ml(5 ×
MEC) and 20 mg/ml(10 × MEC) of CAD were inocu-
lated with spores of Lactobacillus acidophilus (~50
spores/90 mm plate), and incubated at 37°C in an
atmosphere containing 5% CO2 and 95% air for a period
of 72 hr. Control plates were inoculated simultaneously
and incubated in a similar manner. The number of colo-
nies and the size were determined at the end of
experiment.
Effect of CAD on fungal growth
The species of fungi used in the present study was
Candida albicans. Sterile molten potato dextrose agar
(PDA) was poured into sterile Petri dishes (a) with
CAD and (b) without test reagents (as control). The
test plates in triplicate containing 2, 10 and 20 mg/ml
CAD were inoculated with C. albicans spores with a
sterile inoculating loop and incubated at 25-30°C in
an inverted position keeping the agar side up with
increased humidity. Control plates were incubated in
similar manner for 24 hr. The number of colonies
and their size were measured at the end of the
experiment.
Reagents and chemicals
All reagents and chemicals not specifically mentioned (e.
g., TritonX-100, Hematoxylin, Eosin, etc) were pur-
chased from Sigma/Aldrich Chem. Co., St. Louis, MO,
USA.
Statistical analysis
Data are represented as mean ± SEM and significance
was calculated from Student’s t test. P < .05 was consid-
ered as the criterion for statistical significance.
Results
Experiment 1
The percentage of hemolysis was plotted against con-
centrations of CAD and the hemolytic index was deter-
mined from the curve. The results of hemolytic index
studies indicated that concentration required for 50%
hemolysis was 8.2 mg/ml, which is four fold higher than
its spermicidal MEC of CAD (Figure 1).

































Figure 1 Hemolytic index curve of CAD using rabbit
erythrocyte.
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Safety studies in experimental animal model
Low volume eye test (LVET) The rabbits closed their
eyes immediately after treatment and there was no sig-
nificant lapse of time between opening of the two eyes
receiving either CAD or the vehicle; however; the
groups treated with 8.2 mg/ml and 82 mg/ml CAD solu-
tions, exhibited mild blinking. The eyes became normal
after 7(± 1) min. At 1 h post treatment the eyes were
fully open; the pupil was smaller in the treated eyes
than in the control eye, but regained normal size by the
next two hours.
Dermal irritation test There was no persistent
erythema or oedema in any of the animals. The irrita-
tion indices as recorded in different treatment groups
after 24, 48 and 72 hours of treatment are given in the
Table 1.
Experiment-3
Test for possible effect on reproductive performance in
female rats after fourteen daily single dose application
Rats of group I and II were found to be normal and
similar in all aspects. The animals of group III showed
an average prolongation of diestrous phase by one to
two days, but in group IV the vaginal smear showed
persistent diestrous phase from the day after application.
The first proestrous phase appeared in group III (8.2
mg/ml) after 4(± 2) days of cessation of treatment. In
Group IV (82 mg/ml), the animals had their first proes-
trous phase restored 15(± 2) days after discontinuation
of treatment. All the treated animals which regained
their normal proestrous vaginal smear mated success-
fully and completed their pregnancy. The litter size
from their delivery was normal and the pups were
apparently normal. The results suggest that CAD does
not affect female fertility.
Experiment- 4
Effect of 14-day (sub acute) vaginal administration of high
doses of CAD on local tissues, vaginal tissue proliferation
and in situ apoptosis
Effect on local tissues Intra vaginal administration of
CAD at doses up to 82 mg/ml for 14 consecutive days
did not cause any inflammatory reaction in the vaginal
epithelium. Figure 2 shows the representative vaginal
sections of rats. Light microscopic examinations
revealed intact vaginal tissues of rat following daily intra
vaginal administration of K-Y jelly based placebo alone
(Figure 2a) or K-Y jelly based CAD at doses up to 82
mg/ml (Figure 2b). There were slight inflammatory
changes.
PCNA staining Immunohistochemical detection of
PCNA was used to visualize the proliferative activity in
paraffin sections of control (placebo) and CAD treated
vaginal tissues. PCNA positive cells identified as dark
stained nuclei (Figure 3) were present in both control
and CAD treated vaginal epithelium. Table 2 sum-
marizes the percentage of PCNA positive cells in control
and CAD treated vaginal tissues. More than 60% of
vaginal epithelial cells in the placebo group expressed
PCNA and no significant difference in mean percentage
of cells expressing PCNA was observed in tissues treated
with 82 mg/ml CAD, which implies that intra vaginal
administration of CAD did not cause significant reduc-
tion in the number of cycling cells in the vaginal
epithelium.
In situ apoptosis by TUNEL assay TUNEL assay fol-
lowed by fluorescence microscopy revealed that repeated
vaginal administration of CAD at dose 82 mg/ml did
not cause any significant difference in apoptosis in the
female vaginal epithelium as compared to the placebo
group. Only minimal apoptotic cells were detected in
both groups of tissues (Figure 4). There was no signifi-
cant difference in the mean percentage of TUNEL posi-
tive cells among those exposed to K-Y jelly alone (14 ±
0.42%) or to gel containing 82 mg/ml (17 ± 0.71) of
CAD when counted in a microscopic field.
Experiment- 5
Tests for microbicidal activity of CAD
Effect of CAD on Lactobacillus acidophilus Compara-
tive growth of L. acidophilus in agar plate is depicted in
Figure 5. The results showed that CAD did not affect
the number of colonies (control: 30 ± 0.521 and CAD
20 mg/ml: 28 ± 0.421) of Lactobacillus in laboratory
culture at least up to a concentration of 20 mg/ml.
However, there was a significant reduction in individual
colony size, which implies that CAD might have some
adverse effect on Lactobacillus growth.
Effect of CAD on fungal growth There was no fungal
growth in presence of CAD at concentration 20 mg/ml
as depicted in Figure 6. At this dose level, CAD strictly
inhibited the growth of C. albicans.
Discussion
To be an ideal spermicidal contraceptive, the candidate
spermicide should fulfill the following criteria: (i) long-
term application of the spermicide should not bring
local organic irritation, (ii) it should not alter the micro-
bial balance in the female genital tract which may
Table 1 Dermal irritation indices of CAD on rabbit
Treatment Group Irritation indices
24 h 48 h 72 h
Group I (placebo) 0.00 0.00 0.00
Group II (8.2 mg/ml) 1.00 ± 0.5 0.5 ± 0.12 0.00
Group II (82 mg/ml) 2.3 ± 0.41 1.2 ± 0.23 0.06 ± 0.45
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repeated application of the spermicide should not have
any adverse effect on reproductive performances and
subsequent fertility of the female rats. Considering these
points, the toxicity level of CAD was evaluated in
experimental rat and rabbit models.
The hemolytic index is a rapid screening assay of first
order for the assessment of acute irritation potential of
topically applicable microbicide or spermicide [9]. It
helps in the determination of subsequent doses to be
used for toxicity studies. The hemolytic index of CAD
was found to be 8.2 mg/ml, which is four fold higher of
spermicidal MEC. A jell type formulation was made
with K-Y jelly (a non toxic, inert lubricant jelly which is
widely used in human as well as animals) in doses of
CAD ranging up to 10 folds of the hemolytic index (82
mg/ml) was used for local tolerance tests.
The results of 14-day sub acute toxicity studies indi-
cated that the vaginal tissue irritation caused by CAD
was insignificant at doses as high as 82 mg/ml of CAD
and no adverse effect on subsequent fertility was
observed after repeated intra vaginal application of
CAD. On cessation of treatment, when the animals were
allowed to mate, they conceived and delivered normal
off springs indicating that genital tract was not affected
despite repeated exposure to high doses of CAD for 14
consecutive days but the regularity in the estrus cycle of
the treated animals (at dose 82 mg/ml) were affected
may be due to some changes in the submucosal micro-
environment caused by high dose of CAD application.
Further studies are required to explore the effect of
CAD on vaginal cytology. The results of PCNA staining
(Figure 3) and TUNEL assay (Figure 4) showed that
CAD neither hindered the normal cell proliferation of
the vaginal tissues nor caused apoptosis in the rat vagi-
nal cells. This suggested that the spermicidal activity
and ROS mediated DNA damaging potential of CAD is
a cell specific phenomenon rather than a general event
      
a b
Figure 2 Light microscopic images of CAD treated rat vaginal sections. (a) K-Y jelly based control; (b) 82 mg/ml CAD. Compared to the
intact vaginal cell lining in the control sections (a), there were inflammatory changes in the epithelial cell lining of the treated tissue (b). Original
magnification × 200.
       
a b
Figure 3 Light microscopic images of PCNA expression in (a) control (b) CAD treated rat vaginal tissue. Expression of PCNA in control (a)
and CAD (82 mg/ml) treated (b) tissues. Original magnification × 200.
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There is a growing concern that chemical irritations
brought by the long term use of such spermicides dis-
rupt the vaginal mucosa and might actually increase the
risk of STDs including HIV transmission in sexually
active women [2]. The studies on microbicidal activities
of CAD showed that CAD prevents the growth of the
most commonly encountered fungal pathogen of human
vagina, Candida albicans; but the effect of CAD on Lac-
tobacillus c u l t u r ew a sab i td i f f e r e n t .C A Dd i dn o t
prevent the growth of this normal vaginal habitat (Fig-
ure 5) but there was reduction in the individual colony
size in presence of CAD. This implies that CAD might
have some adverse effect on its growth which requires
further investigation. The major constituent of CAD is a
mixture of triterpene glycosides [4] of amphiphilic nat-
ure that is likely to undergo aggregation in solution, and
this might contribute to its irritation potential and
microbicidal effects. Earlier work has demonstrated that
co-precipitation of these amphiphilic compounds with
water-soluble polymers like polyvinylpyrrolidone
decreases their self associating properties of leading to a
decrease in irritation potential without compromising
spermicidal activity [14]. Further investigation in this
direction may be undertaken to reduce the adverse
impact of CAD on Lactobacillus.
Use of a vaginal product, for contraceptive purpose, may
be a life-long practice and as a consequence long term
effect of the product should be considered in a form of
Table 2 Percentage of PCNA positive cells in control and
CAD treated vaginal tissues
Treatment group Mean percentage of PCNA-positive
cells* in the vaginal epithelium
Group I (untreated control) 63 ± 4.5
Group II (KY Jelly) 62.8 ± 5.8
Group III (8.2 mg/ml) 61.5 ± 4.7
Group IV (82 mg/ml) 60.4 ± 5.4
*Mean ± SEM values of groups of three rats
     
a b
Figure 4 The Fluorescence micrograph depicting lack of TUNEL staining of control and CAD treated vaginal tissues. (a) Control tissue
treated with K-Y jelly alone (b) tissues treated with 82 mg/ml CAD. Red fluorescence represents nuclei stained with propidium iodide. Green or
yellow represents apoptotic nuclei containing fragmented DNA. Original magnification × 200.
 
 
                                                        








Figure 5 Growth of Lactobacillus acidophilus in culture plates.
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in animals is needed to identify potential problems with
long-term product use. Either one-year studies in two ani-
mal species (one rodent and one non-rodent), or two year
rodent carcinogenicity bioassays, should be conducted. It
is worthy to mention that the ultimate goal of the study is
for the beneficial of human race and thus the effect of
CAD on human sperm along with the referred studies
have to be considered. The observations made in this
paper, may therefore be viewed as a start in evaluating the
toxicity of CAD for contraceptive goals.
Conclusions
In summary, our present investigation reveals that the
spermicidal effect of CAD is not a non specific surfac-
tant type action on sperm; rather it is a cell specific phe-
nomenon. Local toxicity studies on CAD revealed that
its 14- day daily intra vaginal administration at high
doses neither prevented vaginal tissue proliferation nor
it caused apoptosis to the vaginal tissues and the fertility
potential of the treated animals were restored immedi-
ately after withdrawal of CAD treatment.
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